K130557

Substantially Equivalent

NEURAGEN 3D

Applicant: Integra LifeSciences Corporation
Product code: JXI
Advisory panel: Neurology
Date received: 2013-03-04
Decision date: 2014-04-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Planisboro, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.